Potential role and therapeutic implications of glutathione peroxidase 4 in the treatment of Alzheimer's diseaseYanxin Shen, Guimei Zhang, Chunxiao Wei, Panpan Zhao, Yongchun Wang, Mingxi Li, Li Sun613-631
Cell polarization in ischemic stroke:molecular mechanisms and advancesYuanwei Li, Xiaoxiao Xu, Xuan Wu, Jiarui Li, Shiling Chen, Danyang Chen, Gaigai Li, Zhouping Tang632-645
Toward understanding the role of genomic repeat elements in neurodegenerative diseasesZhengyu An, Aidi Jiang, Jingqi Chen646-659
From single to combinatorial therapies in spinal cord injuries for structural and functional restorationErnesto Doncel-Pérez, Gabriel Guízar-Sahagún, Israel Grijalva-Otero660-670
Crosstalk between degradation and bioenergetics:how autophagy and endolysosomal processes regulate energy productionAngelid Pabon, Jagannatham Naidu Bhupana, Ching-On Wong671-681
Context-dependent role of sirtuin 2 in inflammationNoemí Sola-Sevilla, Maider Garmendia-Berges, MCarmen Mera-Delgado, Elena Puerta682-694
Liver as a new target organ in Alzheimer's disease:insight from cholesterol metabolism and its role in amyloid-beta clearanceBeibei Wu, Yuqing Liu, Hongli Li, Lemei Zhu, Lingfeng Zeng, Zhen Zhang, Weijun Peng695-714
Targeting TrkB-PSD-95 coupling to mitigate neurological disordersXin Yang, Yu-Wen Alvin Huang, John Marshall715-724
Spastin and alsin protein interactome analyses begin to reveal key canonical pathways and suggest novel druggable targetsBenjamin R.Helmold, Angela Ahrens, Zachary Fitzgerald, P.Hande Ozdinler725-739
